Second-generation antidepressant
Second-generation antidepressants are a class of antidepressant drugs that are commonly used in the treatment of major depressive disorder. These drugs are also known as "newer" or "atypical" antidepressants. They include Selective serotonin reuptake inhibitors (SSRIs), Serotonin and norepinephrine reuptake inhibitors (SNRIs), and others such as mirtazapine and bupropion.
Overview[edit | edit source]
Second-generation antidepressants were developed with the aim of improving on the efficacy and safety profile of the first-generation antidepressants, which include tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). They are generally considered to have fewer side effects and are safer in overdose compared to first-generation antidepressants.
Mechanism of Action[edit | edit source]
Second-generation antidepressants work by altering the levels of neurotransmitters in the brain, particularly serotonin and norepinephrine. SSRIs work by blocking the reuptake of serotonin, thereby increasing its availability in the brain. SNRIs block the reuptake of both serotonin and norepinephrine. Other second-generation antidepressants have different mechanisms of action. For example, mirtazapine increases the release of norepinephrine and serotonin, while bupropion inhibits the reuptake of norepinephrine and dopamine.
Efficacy[edit | edit source]
Second-generation antidepressants are generally considered to be as effective as first-generation antidepressants in treating major depressive disorder. However, individual response to these drugs can vary greatly, and some people may find one drug more effective than another.
Side Effects[edit | edit source]
Common side effects of second-generation antidepressants include nausea, dry mouth, and sexual dysfunction. These side effects are generally less severe and occur less frequently than with first-generation antidepressants. However, they can still be bothersome and may lead to discontinuation of treatment in some cases.
See Also[edit | edit source]
- First-generation antidepressants
- Major depressive disorder
- Selective serotonin reuptake inhibitors
- Serotonin and norepinephrine reuptake inhibitors
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
